Blog
Essays from the desk.
Clinical AI, longevity clinics, neurotech and the Portugal ecosystem — architecture-lens essays with named researchers, not thought-leader mush.
28 / 28
NAD+ IVs in Porto: Just a Drip?
NAD+ IVs are everywhere in Porto. Do they deliver more than just a momentary lift?
The 112 Clinic's Senolytic Cocktail: Hype or Longevity Fix?
The 112 Clinic in Lisbon markets a senolytic cocktail for longevity. We dissect if their claims are backed by human data, or if we're seeing more preclinical promise than clinical reality.
Neurotech: Beyond BCI001's 'Thought-to-Text' Claims
Your 'thought-to-text' device isn't reading your mind. It's predicting your next word. The implications are enormous.
WHO/Europe met in Lisbon to govern health AI. Three-quarters of the EU already uses AI diagnostics — only three states have a health-AI strategy.
On 15–16 July 2026, WHO/Europe and Portugal co-hosted a high-level meeting on governing AI in health. The gap between deployment and governance is now the story.
Lisbon's 'Blue Zone' Myth: Beyond Sardines & Sunshine
Lisbon wants to be a Blue Zone. Great. But is it? Let's check the data.
Porto's Biofeedback: Beyond Meditation App Hype
Forget guided meditations. Porto's neurotech outfits are building for tangible change, one neural oscillation at a time.
Best health gadgets for longevity in 2026: an operator's guide
An operator-side guide to the health gadgets actually worth putting into a 2026 longevity, sleep and recovery stack — judged by the biomarkers they move, not the marketing.
The AI-native wellness operator — a new business shape.
Solo founders and 2-4 person teams are running credible wellness product companies at the scale of what used to require 20. What the AI-native operator stack actually looks like inside a wellness or clinical-adjacent business.
Your brain does not decide you are happy. Your body does.
Embodied cognition is not a metaphor. New neuroscience shows physical inputs — posture, chair hardness, walking, water, novelty — measurably shift mood, negotiation and creativity. What that means for wellness product design.
Youth mental health is not a therapy problem. It is an ecosystem problem.
The UN Youth Office's 2026 #RealPeopleRealTalk framing lands on the same conclusion clinicians have been reaching for a decade: prevention and shared responsibility, across education, digital, spiritual, climate and community, define the next generation of mental health action.
Portugal is quietly assembling a full health-tech stack.
Health Cluster Portugal, HealthAI GRN membership, SPMS's national digital-health backbone, and a growing longevity-clinic layer. Why this stack matters for founders, investors and operators looking at Southern Europe.
Porto's Nootropics: Hype, Hazard, and Hope for Oversight
Porto's 'smart drug' scene promises cognitive gains. What's actually happening in your brain, and who's watching?
Oura Ring Data: Beyond Activity Tracking to Early Disease Markers
Your Oura Ring isn't just counting steps. It might be quietly alerting you to disease onset, if we knew how to listen.
Portugal's Digital Health Strategy: 5-Year Impact Review
Five years in, did Portugal's digital health strategy deliver on patient access? The ledger is more complex than official narratives suggest.
Coimbra's AI Pathology: Diagnosis, Not Prediction
Coimbra isn't predicting cancer with AI. They're diagnosing it. What does that mean for accuracy?
Mind Over Migraine: Porto's Neurotech Focus on Non-Invasive CES
Forget the 'migraine cocktail'. Porto's neurotech sector builds better brains, one non-invasive zap at a time.
Algarve's Longevity Secret: NAD+ IVs & Peptide Protocols
Forget the 'Mediterranean diet' hype. The Algarve's true longevity play involves IV drips and molecular messengers.
Biotech Valley Português: Lisbon Navigates the EU AI Act
EU AI Act lands in Lisbon. Biotech moves from compliance to competitive advantage.
The Algarvian Protocol: Blue Zones, Tech, and Regional Wellness
Forget isolated longevity lessons. The Algarve can architect a regional wellness system, leveraging ancestral wisdom and modern tech.
Portable Neurofeedback for Executive Function: Beyond the Clinic Walls
Clinic-grade neurofeedback is leaving the lab. The architecture of attention demands it.
Algarve's Biometric Data: Patient Rights at Risk?
The Algarve is collecting biometric data at scale. Are we sleepwalking into a privacy disaster?
OpenAI's Healthcare Bet: Dissecting the Clinic vs. Consumer Split
OpenAI's healthcare play isn't a silver bullet. Understand its true impact on clinics, consumers, and your European wellness operation.
Lisbon's AI Gambit: Mount Sinai Reimagines Portuguese Oncology
Forget incremental progress. Lisbon’s Mount Sinai partnership isn’t just tweaking oncology; it’s overhauling the diagnostic architecture.
Faro's BrainPort: Neurofeedback as ADHD & Anxiety Intervention
Faro's BrainPort isn't just treating symptoms; it's re-architecting the brain. A deep dive into neurofeedback's audacious claim.
The top 5 wellness tech innovations to watch in 2027
A curated editorial guide to the wellness tech worth paying attention to in 2027 — continuous biomarkers, closed-loop neuromodulation, longevity clinics, AI care copilots and connected recovery.
Anthropic wants to make drugs. Read the incentive.
When the model vendor becomes the drugmaker, the pipeline is no longer neutral infrastructure — it is a distribution channel with a preferred customer.
Portuguese Longevity Clinics: Decoding the Sesimbra Study
Turns out, 'age reversal' isn't real. Biometric improvements? That's a different story. The Sesimbra Cohort Study delivers.
Portugal Just Became the EU's AI-in-Health Test Bed
Infarmed joined HealthAI's Global Regulatory Network the same week the EU AI Act rules are landing — here's what that actually changes for clinicians, device makers and founders shipping into Europe.